Ulland Investment Advisors’s Hims & Hers Health HIMS Stock Holding History

Ulland Investment Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5	Closed	–	–	221
2025 Q1	$0	Buy	+5	New	+$186	﹤0.01%	223

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Ulland Investment Advisors's HIMS Position: Q2 2025 in Review

Ulland Investment Advisors sold out of Hims & Hers Health (HIMS) in Q2 2025, closing a stake of 5 shares.

Ulland Investment Advisors first reported a position in HIMS in Q1 2025 and held it in 1 quarter. The position peaked at $0 in Q1 2025. 510 funds tracked by Wall St. Rank hold HIMS as of Q2 2025.

Ulland Investment Advisors reported no remaining Hims & Hers Health position as of Q2 2025 after selling out during the quarter.
Ulland Investment Advisors sold 5 Hims & Hers Health shares in Q2 2025.
Ulland Investment Advisors first reported a position in Hims & Hers Health in Q1 2025 and held it in 1 quarter.
Ulland Investment Advisors's Hims & Hers Health position peaked at $0 in Q1 2025.
510 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2025.

Based on Ulland Investment Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.